ImageneBio (IMA) FCF Margin (2020 - 2024)
Historic FCF Margin for ImageneBio (IMA) over the last 5 years, with Q3 2024 value amounting to 370.34%.
- ImageneBio's FCF Margin rose 20578500.0% to 370.34% in Q3 2024 from the same period last year, while for Dec 2024 it was 1314.4%, marking a year-over-year decrease of 4394200.0%. This contributed to the annual value of 875.08% for FY2023, which is 3914000.0% down from last year.
- Per ImageneBio's latest filing, its FCF Margin stood at 370.34% for Q3 2024, which was up 20578500.0% from 3350.68% recorded in Q4 2023.
- ImageneBio's 5-year FCF Margin high stood at 370.34% for Q3 2024, and its period low was 20320.0% during Q4 2020.
- Over the past 5 years, ImageneBio's median FCF Margin value was 403.25% (recorded in 2021), while the average stood at 2060.17%.
- As far as peak fluctuations go, ImageneBio's FCF Margin surged by 202511600bps in 2021, and later plummeted by -48817800bps in 2022.
- Quarter analysis of 5 years shows ImageneBio's FCF Margin stood at 20320.0% in 2020, then soared by 100bps to 68.84% in 2021, then crashed by -377bps to 328.18% in 2022, then crashed by -921bps to 3350.68% in 2023, then surged by 111bps to 370.34% in 2024.
- Its FCF Margin stands at 370.34% for Q3 2024, versus 3350.68% for Q4 2023 and 1687.51% for Q3 2023.